Direkt zum Inhalt
Merck

[Primary hyperchylomicronemia].

Nihon rinsho. Japanese journal of clinical medicine (2013-11-12)
Shizuya Yamashita
ZUSAMMENFASSUNG

Primary hyperchylomicronemia is characterized by a marked hypertriglyceridemia due to an increase in chylomicrons, which may cause acute pancreatitis and eruptive xanthomas. This entity includes familial lipoprotein lipase (LPL) deficiency, familial apolipoprotein C-II deficiency, primary type V hyperlipoproteinemia, and idiopathic hyperchylomicronemia. Idiopathic hyperchylomicronemia is caused by an LPL inhibitor or autoantibody against LPL. More recently, patients with primary hyperchylomicronemia caused by mutations in the gene for glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1(GPIHBP1) or lipase maturation factor 1(LMF1). For the treatment of primary hyperchylomicronemia, a strict restriction of dietary fat is essential to avoid acute pancreatitis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Lipoprotein-Lipase aus Kuhmilch, ammonium sulfate suspension, ≥2,000 units/mg protein (BCA)
Sigma-Aldrich
Lipoprotein-Lipase aus Pseudomonas sp., lyophilized, powder, ≥1200 U/mg
Sigma-Aldrich
Lipoprotein-Lipase aus Pseudomonas sp., lyophilized powder, ≥50,000 units/mg solid